Tool to interrogate new class of drugs

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that

Related Keywords

Yi Zhao Sruthi Raja ,Jesser Poganik ,Saba Parvez ,Nature Communications ,European Medicines Agency ,Cornell University ,Professor Yimon Aye ,Kuan Ting Huang ,Sruthi Raja ,Necessary Mediators ,Immune Cell Specific Apoptosis Triggered ,